137 related articles for article (PubMed ID: 3243217)
1. Extracorporeal methods in the management of severe and malignant arterial hypertension.
Arabidze GG; Kukharchuk VV; Kutsenko AI; Legkonogov AV; Zaruba AYu
Health Psychol; 1988; 7 Suppl():113-25. PubMed ID: 3243217
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of refractory arterial hypertension by plasmapheresis].
Kutsenko AI; Kukharchuk VV; Legkonogov AV; Arabidze GG; Zaruba AIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):71-7. PubMed ID: 3401344
[TBL] [Abstract][Full Text] [Related]
3. [Use of plasmapheresis in the treatment of patients with severe arterial hypertension refractory to drug therapy].
Legkonogov AV; Kutsenko AI; Zaruba AIu; Arabidze GG; Kukharchuk VV
Ter Arkh; 1988; 60(6):60-4. PubMed ID: 3206373
[TBL] [Abstract][Full Text] [Related]
4. [The renin-angiotensin-aldosterone system and antidiuretic hormone secretion during plasmapheresis in patients with high arterial hypertension refractory to drug therapy].
Kukharchuk VV; Legkonogov AV; Kutsenko AI; Masenko VP; Arabidze GG
Kardiologiia; 1988 Jan; 28(1):10-4. PubMed ID: 3357290
[TBL] [Abstract][Full Text] [Related]
5. [Plasmapheresis in the treatment of severe and malignant arterial hypertension].
Legkonogov AV; Kukharchuk VV; Kutsenko AI; Arabidze GG; Zaruba AIu
Sov Med; 1988; (10):38-42. PubMed ID: 3242094
[No Abstract] [Full Text] [Related]
6. [Clinico-immunological assessment of the effectiveness of plasmapheresis in the combined therapy of patients with high arterial hypertension].
Legkonogov AV; Kukharchuk VV; Osipov SG; Kutsenko AI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):25-9. PubMed ID: 3606831
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and hemodynamic evaluation of the effectiveness of plasmapheresis in high arterial hypertension refractory to drug treatment agents].
Legkonogov AV; Kheĭmets FI; Kukharchuk VV; Kutsenko AI; Ragimov SE
Ter Arkh; 1988; 60(5):80-5. PubMed ID: 3175935
[TBL] [Abstract][Full Text] [Related]
8. [Hemosorption in the combined treatment of patients with symptomatic malignant hypertension].
Kutsenko AI; Arabidze GG; Kukharchuk VV; Zaruba AIu; Rakhmedov DR
Ter Arkh; 1987; 59(4):106-8. PubMed ID: 3589984
[TBL] [Abstract][Full Text] [Related]
9. [Hypotensive effect of plasmapheresis in patients with severe symptomatic arterial hypertension of renal origin].
Kutsenko AI; Legkonogov AV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):87-90. PubMed ID: 3606838
[TBL] [Abstract][Full Text] [Related]
10. [Use of extracorporeal methods of purifying the blood in the combined treatment of patients with symptomatic renal artery hypertension with a stable and with a malignant course].
Zaruba AIu; Legkonogov AV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):111-2. PubMed ID: 3801129
[No Abstract] [Full Text] [Related]
11. [Effectiveness of isolation ultracentrifugation in the combined treatment of heart failure refractory to therapy developing in the presence of severe arterial hypertension with stable and malignant courses].
Zaruba AIu; Kutsenko AI; Kukharchuk VV; Kotkina TI
Kardiologiia; 1987 Dec; 27(12):20-3. PubMed ID: 3444205
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the combined use of hemosorption and plasmapheresis on the blood rheological and hemodynamic indices of hypertension patients].
Konopleva LF; Ena IaM; Karpenko VV; Sushko EA; Voĭtovich NS; Shekhter IE
Klin Med (Mosk); 1992 Jan; 70(1):54-6. PubMed ID: 1608213
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis combined with hemosorption in the treatment of hypertension patients].
Konopleva LF; Karpenko VV; Ena IaM; Sushko EA; Voĭtovich NS
Vrach Delo; 1991 Jul; (7):32-4. PubMed ID: 1771829
[TBL] [Abstract][Full Text] [Related]
14. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
15. [Extracorporeal detoxification (hemosorption, plasmapheresis and plasma exchange) in the intensive therapy of hemolytic disorders].
Starikov AV; Romanova AF; Beschastnaia SP; Belaia TI
Anesteziol Reanimatol; 1990; (4):16-7. PubMed ID: 2077958
[TBL] [Abstract][Full Text] [Related]
16. [Use of prostenon in the treatment of severe and malignant forms of hypertension].
Runikhin AIu; Nekrasova AA; Arabidze GG; Elizarova NA; Panfilov VV
Kardiologiia; 1986 Dec; 26(12):76-81. PubMed ID: 3470553
[TBL] [Abstract][Full Text] [Related]
17. [Plasmapheresis in the treatment of patients with hypertension].
Ananchenko VG; Kuznetsov SV; Alizade IG; Karaeva NT
Sov Med; 1991; (10):20-2. PubMed ID: 1801226
[TBL] [Abstract][Full Text] [Related]
18. [Changes in arterial pressure and concentration of several hormones in the blood effected by hemosorption in patients with arterial hypertension caused by parenchymatous diseases of the kidneys].
Kutsenko AI; Arabidze GG; Kukharchuk VV; Masenko VP; Zaruba AIu
Ter Arkh; 1987; 59(12):15-7. PubMed ID: 2833821
[TBL] [Abstract][Full Text] [Related]
19. [The use of hemosorption and plasmapheresis for treating cardiac arrhythmias (a preliminary report)].
Nedostup AV; Panasiuk VV; Boldyrev DA; Kalugina GV; Ivanov MI; Komiagin IuV
Ter Arkh; 1994; 66(8):35-6. PubMed ID: 7985150
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of arterial hypertension by plasmapheresis].
Glasson P
Schweiz Med Wochenschr; 1983 Feb; 113(5):189-91. PubMed ID: 6340184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
